Skip to Main Content

Paper Details

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
Cancer
20
2021
/, BRCA, BRCA1, BRCA1/2, BRCA2, PARP, PARPi, PDAC, Pancreas cancer, Patients, Platinum, g, g/sBRCA1/2, g/sBRCA1/2 mutations, gBRCA1/2, pancreas ductal adenocarcinoma, patients, platinum, poly(adenosine diphosphate ribose), poly(adenosine diphosphate ribose) polymerase, sBRCA1/2
Author NameAffiliation
Chaitanya BandlamudiKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Michael F BergerKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Debyani ChakravartyKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Debyani ChakravartyMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2